The growth of the EPS is critical in understanding the current valuation of Celcuity. It is usually expressed as a percentage and is then referred to as the EPS growth rate, which at this time is unavialble, but historically the EPS change was 18.18% over the last twelve months. The long-term trend in EPS shows how well the management of Celcuity is adding value for shareholders.
Celcuity is part of the medical diagnostics and research industry and is in the healthcare sector. The company CEO is Brian F. Sullivan. Celcuity Inc is a cellular analysis company. The company is discovering new cancer sub-types and commercializing diagnostic tests.
Previous Intraday Performance:
The CELC shares had a previous change of -2.00% which opened at 27.13 and closed at 26.90. It moved to an intraday high of 28.00 and a low of 26.90.
SeekingAlpha: Celcuity (CELC) CEO Brian Sullivan on Q3 2018 Results – Earnings Call Transcript
Historical Performance:
Over the last five trading days, CELC shares returned 4.26% and in the past 30 trading days it returned -4.88%. Over three months, it changed 3.70%. In one year it has changed 43.24% and within that year its 52-week high was 31.00 and its 52-week low was 13.16. CELC stock is 104.41% above its 52 Week Low.
Our calculations result in a 200 day moving average of 22.41 and a 50 day moving average of 27.47. Right now, CELC stock is trading 20.03% above its 200 day moving average.
SeekingAlpha: Celcuity (CELC) CEO Brian Sullivan on Q3 2018 Results – Earnings Call Transcript
Liquidity:
The company has a market cap of $272.2m with 10.1m shares outstanding and a float of 6.0m shares. Trading volume was 9,472 shares and has experienced an average volume of 9,709 shares. Our calculation, using the current average volume and close price, leads me to believe that the liquidity is bad, highly speculative and an investor may want to avoid this stock.
Earnings:
The last annual reported EPS for Celcuity was -0.69 which ended on 31st of December 2017.
Below was the last reported quarterly earnings per share:
09-30-2018: -0.18
06-30-2018: -0.15
03-31-2018: -0.19
12-31-2017: -0.17
Indicators Also to Watch:
Based on the latest filings, there is 40.50% of insider ownership and 13.50% of institutional ownership. Short-interest was 0, which was 0.00% of shares outstanding. The short-interest ratio or days-to-cover ratio was 0.00.
I calculated the beta to be 0.00
SeekingAlpha: Notable earnings before Tuesday’s open
Fundamental Numbers:
Based on last reported financials, the company’s return on equity is -24.71%, return on assets is -24.18% and price-to-book is 9.19.
Company Score Card:
Results are out of six:
0 : Growth Expectations Result
5 : Financial Safety Result
0 : Past Performance Result
0 : Valuation Result
0 : Dividend Safety Result
1 : Overall Result
Related Tags: CELC, Celcuity, Healthcare, Medical Diagnostics And Research
